Related Experiment Video
Updated: Jun 6, 2026

Fecal Glucocorticoid Analysis: Non-invasive Adrenal Monitoring in Equids
Published on: April 25, 2016
Evaluation Of Dheas (Dehydroepiandrosterone Sulfate) Levels In Patients With Adrenal Adenomas Exhibiting Autonomous
Ulcaz Perihan Aksoydan Zubaroglu1, Gamze Akkus2, Bekir Tamer Tetiker2
1Division of Endocrinology and Metabolism, Department of Internal Medicine, Faculty of Medicine, Mersin University, Mersin, Turkey; Division of Endocrinology and Metabolism, Department of Internal Medicine, Faculty of Medicine, Cukurova University, Adana, Turkey.
Background:
Autonomous cortisol secretion (ACS) is the most common hormonal dysfunction in adrenal incidentalomas and is associated with increased cardiometabolic morbidity. Dehydroepiandrosterone sulfate (DHEAS), an ACTH-dependent adrenal steroid, may decrease in ACS due to hypothalamic-pituitary-adrenal axis suppression. This study evaluated the diagnostic utility of DHEAS and DHEAS-based ratios, particularly within a dexamethasone suppression test (DST)-integrated framework, for differentiating ACS from non-functioning adrenal adenomas (NFA).
Methods:
In this retrospective single-center study, records of 433 patients followed for adrenal incidentaloma between 2015 and 2021 were reviewed. After applying predefined criteria, 67 patients were included: 35 with ACS and 32 with NFA. ACS was defined using a post-1 mg DST cortisol threshold of ≥ 1.8 µg/dL and confirmed with a two-day low-dose DST. Clinical, metabolic, biochemical, hormonal, and radiological parameters were analyzed. ROC analyses and logistic regression were performed, and internal validation was conducted using bootstrapping with 1,000 iterations.
Results:
Comorbidities were more frequent in ACS. ACTH, DHEAS, DHEAS/cortisol ratio, DHEAS/1-mg DST cortisol ratio, and TyG index differed significantly between groups. Post-1 mg DST cortisol showed the highest discriminatory performance (AUC = 0.967). Although DHEAS alone had limited diagnostic utility, the DHEAS/1-mg DST cortisol ratio showed good discrimination (AUC = 0.884, 95% CI: 0.802-0.966) and remained the only independent predictor of ACS (OR: 0.931, 95% CI: 0.895-0.968, p < 0.001). TyG showed moderate discrimination but was not an independent predictor.
Conclusion:
The DHEAS/1-mg DST cortisol ratio may serve as a useful adjunctive marker for ACS-NFA differentiation, especially in borderline or ambiguous cases, but requires prospective external validation.
Related Concept Videos
Adrenal Gland Disorders
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
Cushing Syndrome II: Pathophysiology
Cushing Syndrome I: Introduction
Hormones of the Adrenal Glands
The adrenal cortex, a powerhouse of hormone synthesis, generates over two dozen corticosteroid hormones. The zona glomerulosa produces mineralocorticoids, exemplified by aldosterone, influencing the electrolyte composition of body fluids. The synthesis of glucocorticoids such as cortisol and corticosterone...
Hypothalamic-Pituitary Axis
Anatomy of the Adrenal Glands
These glands possess a distinctive yellow tinge due to the stored cholesterol and fatty acids required for hormone synthesis. They are encased in a fibrous capsule and cushioned by fat.
The adrenal gland comprises two distinct regions...

